Erythrocytosis incidence and thromboembolic risk in heart failure with reduced ejection fraction treated with SGLT2 inhibitors: a nationwide register-based cohort study. - Mohamed AA; Andersen CF; Christensen DM; Riis-Vestergaard LD; Mohammad M; Elmegaard M; Binding C; Torp-Pedersen C; Biering-Sørensen T; Hansen ML; Køber L; Glenthøj A; et al. (Cardiovascular diabetology, 2025)